SCHEMBL10040966

SCHEMBL10040966

C=Cc1ccc(Cl)c(C(=O)Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 5/20 0.38
TP53 P04637 1/20 0.38
MCL1 Q07820 2/20 0.35
BCL2L11 O43521 1/20 0.34
BCL2L1 Q07817 1/20 0.34
TDP1 Q9NUW8 2/20 0.34
TRPA1 O75762 1/20 0.34
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
POLB P06746 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
GUSB P08236 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10041228 0.85 ALDH1A1 (0.57) ALDH1A1TP53MCL1TDP1POLB
SCHEMBL29641926 0.79 MEN1 (0.49) HPGDALDH1A1TP53TRPA1PTGS2
SCHEMBL13816956 0.75 CYP4F2 (0.58) HPGDALDH1A1MCL1KDM4EKMT2A
SCHEMBL10041230 0.74 ALDH1A1 (0.42) HPGDCYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL23159925 0.74 TDP1 (0.37) ALDH1A1TP53MCL1TDP1TRPA1
SCHEMBL1164171 0.73 TSHR (0.57) HPGDCYP1A2ALDH1A1TP53MCL1
SCHEMBL23164993 0.73 MCL1 (0.31) ALDH1A1MCL1
SCHEMBL699001 0.73 ALDH1A1 (0.68) HPGDCYP1A2CYP3A4CYP2C19ALDH1A1
Formic Acid SCHEMBL27776658 0.72 ALDH1A1 (0.59) ALDH1A1TDP1NPC1RAB9AGUSB
SCHEMBL14890 0.72 ALDH1A1 (0.58) CYP3A4ALDH1A1TP53TDP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012019496-A1 C-ARYL GLUCOSIDE DERIVATIVES, PREPARATION RPOCESS AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-02-16 WO disclosed